Clinical Trials for Small Lymphocytic Lymphoma (SLL)

Predictors of Health-Related QOL in Adults With CLL or Small Lymphocytic Lymphoma

NCT ID: NCT07030400

This clinical trial is studying how adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) feel over time while receiving treatment. The researchers want to learn more a...

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

NCT ID: NCT05131022

This clinical trial is studying a new medication called NX-5948 to see how safe it is and how well it can help adults with certain types of advanced B-cell cancers, such as Chronic Lymphocytic Leuk...

Assessing Minimal Residual Disease by Next- Generation Sequencing to Minimize Exposure in People With CLL or SLL Who Have Been Treated With Venetoclax

NCT ID: NCT04419519

This clinical trial is looking at whether people with Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) can safely stop taking a medication called venetoclax after their diseas...

Phase 2 Study of Disease Risk Mutation-Guided Finite Acalabrutinib+Venetoclax for Relapsed CLL Post-1L Finite cBTKi+BCL2i ± Obinutuzumab

NCT ID: NCT07024706

This clinical trial is studying a new treatment approach for people with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who have had their cancer come back after initial the...

Zanubrutinib and Venetoclax in CLL (ZANU-VEN)

NCT ID: NCT05168930

The ZANU-VEN clinical trial is studying the combination of two medications, zanubrutinib and venetoclax, to see how effective they are in treating patients with chronic lymphocytic leukemia (CLL) o...

A Study of Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

NCT ID: NCT02966756

This clinical trial is studying a medication called venetoclax in patients who have relapsed or refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL). This means the can...

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

NCT ID: NCT04830137

This clinical trial is investigating a new treatment called NX-2127 for adults with certain types of advanced B-cell cancers, such as Chronic Lymphocytic Leukemia (CLL) and various types of lymphom...

Zanubrutinib, Obinutuzumab, and Sonrotoclax in Previously Untreated Patients with CLL or SLL

NCT ID: NCT06849713

This clinical trial is investigating a new treatment combination of three medications—Zanubrutinib, Obinutuzumab, and Sonrotoclax—for patients who have been newly diagnosed with Chronic Lymphocytic...

A Study of Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Treated With Lisocabtagene Maraleucel in the Post-Marketing Setting

NCT ID: NCT06788639

This clinical trial is focused on studying the long-term safety of a treatment called lisocabtagene maraleucel (often referred to as liso-cel) in patients with relapsed or refractory chronic lympho...

Long-term Follow-up Study for Patients Treated With CLBR001 CAR-T

NCT ID: NCT04488354

Phase I/II Open-label Study Evaluating The Safety And Efficacy of Concomitant Administration of Anti-CD19 CAR T-cell Therapy and Lenalidomide in Refractory/Relapsed Chronic Lymphocytic Leukemia Patients.

NCT ID: NCT06762431

A Study of Voruciclib Alone or in Combination With Venetoclax in Subjects With B-Cell Malignancies or AML

NCT ID: NCT03547115

This clinical trial is studying a medication called voruciclib, both on its own and in combination with another drug called venetoclax, to see how safe and effective they are for patients with cert...